ESSD Commentary on Dysphagia Management During COVID Pandemia

  • PDF / 404,430 Bytes
  • 4 Pages / 595.276 x 790.866 pts Page_size
  • 62 Downloads / 167 Views

DOWNLOAD

REPORT


COMMENT

ESSD Commentary on Dysphagia Management During COVID Pandemia Antonio Schindler1 · Laura W. J. Baijens2,3 · Pere Clave4,5 · Bjorn Degen6 · Stephanie Duchac7 · Rainer Dziewas8 · Daniele Farneti9 · Shaheen Hamdy10 · Emilia Michou11 · Peter Pokieser12 · Renee Speyer13 · Margaret Walshe14 · Eric Verin15 · Nathalie Rommel16,17  Received: 3 June 2020 / Accepted: 23 September 2020 © Springer Science+Business Media, LLC, part of Springer Nature 2020

Abstract Since the World Health Organization declared the COVID-19 pandemic a Global Public Health Emergency, experts in swallowing are seeking guidance on service delivery and clinical procedures. The European Society for Swallowing Disorders provides considerations to support experts in swallowing disorders in clinical practice. During the COVID-19 pandemic, assessment and treatment of patients with oropharyngeal dysphagia should be provided, while at the same time balancing risk of oropharyngeal complications with that of infection of patients and healthcare professionals involved in their management. Elective, non-urgent assessment may be temporarily postponed and patients are triaged to decide whether dysphagia assessment is necessary; instrumental assessment of swallowing is performed only if processing of the instruments can be guaranteed and clinical assessment has not provided enough diagnostic information for treatment prescription. Assessment and management of oropharyngeal dysphagia is a high-risk situation as it must be considered an aerosol-generating procedure. Personal protective equipment (PPE) should be used. Telepractice is encouraged and compensatory treatments are recommended. Keywords  COVID-19 · Dysphagia · Assessment · Personal protective equipment * Nathalie Rommel [email protected] 1

10

GI Sciences, School of Medical Sciences, Clinical Sciences Building, University of Manchester, Salford Royal Hospital, Salford M6 8HD, UK



Phoniatric Unit, Department of Biomedical and Clinical Science “L. Sacco”, University of Milan, Milan, Italy

11



Department of Otorhinolaryngology, Head and Neck Surgery, Maastricht University Medical Center, Maastricht, The Netherlands

Department of Speech Language Therapy, School of Rehabilitation Sciences, University of Patras, Patras, Greece

12

Unified Patient Program, Teaching Center, Medical University of Vienna, Vienna, Austria

13

Department Special Needs Education, University of Oslo, Oslo, Norway

14

Department of Clinical Speech and Language Studies, Trinity College Dublin, The University of Dublin, Dublin 2, Ireland

15

Rouen University Hospital, University of Rouen, 3830 Normandy, EA, France

16

Dept of Neurosciences, ExpORL, Deglutology and University Hospital Leuven, University of Leuven, Leuven, Belgium

17

Dept Gastroenterology (Neurogastroenterology and Motility), University of Leuven, Leuven, Belgium

2

3

GROW‑School for Oncology and Developmental Biology, Maastricht University Medical Center,, Maastricht, The Netherlands

4

Gastrointestinal Physiology Laboratory. Hospital de